Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches

Lina N Zaripova1, Angela Midgley2, Stephen E Christmas3

  • 1Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, William Henry Duncan Building, 6 West Derby Street, Liverpool, L7 8TX, UK.

Insights

Juvenile idiopathic arthritis (JIA) is a complex paediatric inflammatory disease. Advances in understanding its pathogenesis and treatments offer improved outcomes, but further research is needed for non-responsive patients.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Inflammatory Diseases

Background:

  • Juvenile idiopathic arthritis (JIA) is the most common rheumatological condition in children.
  • JIA encompasses diverse subtypes based on clinical and serological criteria.

Purpose of the Study:

  • To review advances in JIA pathogenesis, including etiology, histopathology, and immunology.
  • To discuss current and emerging therapeutic strategies for JIA management.

Main Methods:

  • Literature review of JIA pathogenesis and treatment options.
  • Analysis of immunological changes associated with disease activity.
  • Evaluation of non-biologic and biologic disease-modifying anti-rheumatic drugs (DMARDs).

Main Results:

  • Significant progress in understanding JIA as a group of inflammatory diseases.
  • Improved clinical outcomes with advanced therapeutics, including biologics.
  • A subset of patients shows limited response to current treatments.

Conclusions:

  • Enhanced understanding of JIA pathogenesis is crucial for targeted therapies.
  • Further research is required to optimize treatment stratification and improve outcomes for all JIA patients.
  • Personalized treatment approaches are essential for managing JIA effectively.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
939
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
859
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
245
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
65
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
119